A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Allylprodine
Alclofenac
The risk or severity of hypertension can be increased when Alclofenac is combined with Dihydroergocristine.
Allylprodine
Amitriptylinoxide
The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Dihydroergocristine.
Allylprodine
Tramazoline
The risk or severity of hypertension can be increased when Tramazoline is combined with Dihydroergocristine.
Allylprodine
Tinoridine
The risk or severity of hypertension can be increased when Tinoridine is combined with Dihydroergocristine.
Allylprodine
Opipramol
The risk or severity of hypertension can be increased when Opipramol is combined with Dihydroergocristine.
Allylprodine
Urapidil
The risk or severity of hypertension can be increased when Urapidil is combined with Dihydroergocristine.
Allylprodine
Ebselen
The risk or severity of hypertension can be increased when Ebselen is combined with Dihydroergocristine.
Allylprodine
Idazoxan
The risk or severity of hypertension can be increased when Idazoxan is combined with Dihydroergocristine.
Allylprodine
Indobufen
The risk or severity of hypertension can be increased when Indobufen is combined with Dihydroergocristine.
Allylprodine
Nitroaspirin
The risk or severity of hypertension can be increased when Nitroaspirin is combined with Dihydroergocristine.
Allylprodine
Flunixin
The risk or severity of hypertension can be increased when Flunixin is combined with Dihydroergocristine.
Allylprodine
Atipamezole
The risk or severity of hypertension can be increased when Atipamezole is combined with Dihydroergocristine.
Allylprodine
Tepoxalin
The risk or severity of hypertension can be increased when Tepoxalin is combined with Dihydroergocristine.
Allylprodine
Robenacoxib
The risk or severity of hypertension can be increased when Robenacoxib is combined with Dihydroergocristine.
Allylprodine
Oxaprotiline
The risk or severity of hypertension can be increased when Oxaprotiline is combined with Dihydroergocristine.
Allylprodine
Talniflumate
The risk or severity of hypertension can be increased when Talniflumate is combined with Dihydroergocristine.
Allylprodine
Morniflumate
The risk or severity of hypertension can be increased when Morniflumate is combined with Dihydroergocristine.
Allylprodine
Caroxazone
The risk or severity of hypertension can be increased when Caroxazone is combined with Dihydroergocristine.
Allylprodine
Safrazine
The risk or severity of hypertension can be increased when Safrazine is combined with Dihydroergocristine.
Allylprodine
Pivhydrazine
The risk or severity of hypertension can be increased when Pivhydrazine is combined with Dihydroergocristine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3